Novel Approaches to Control of the Alternative Complement Pathway for the Treatment of C3 Glomerulopathies

Mohamed R. Daha*, Marc Seelen

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)2032-2033
Number of pages2
JournalJournal of the American Society of Nephrology
Volume29
Issue number8
DOIs
Publication statusPublished - Aug-2018

Keywords

  • complement
  • C3G
  • inhibitor

Cite this